Pharmacogenetic landscape of clopidogrel in north Indians suggest distinct interpopulation differences in allele frequencies

Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine

(2013) Mohd Zaki Salleh et al.   PLoS One

Genome-Wide Association Study for Type 2 Diabetes in Indians Identifies a New Susceptibility Locus at 2q21

(2012) R. Tabassum et al.   DIABETES

Systematic analysis and functional annotation of variations in the genome of an Indian individual

(2012) Ashok Patowary et al.   HUMAN MUTATION

Current status of clopidogrel pharmacogenomics

(2012) Betti Giusti et al.   PHARMACOGENOMICS

Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin

(2012) Payman Shahabi et al.   PHARMACOGENOMICS

CYP2C19 and PON1 polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and Indian subjects

(2012) Mark Y Chan et al.   PHARMACOGENOMICS

Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms

(2012) Rakhee Kar et al.   PLATELETS

CYP2C19 But Not PON1 Genetic Variants Influence Clopidogrel Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy in Post–Myocardial Infarction Patients

(2011) Jean-Sébastien Hulot et al.   Circulation-Cardiovascular Interventions

CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study

(2010) A. M. Harmsze et al.   EUROPEAN HEART JOURNAL

Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI

(2010) Jessica L. Mega et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis

(2010) Jessica L Mega et al.   LANCET

Paraoxonase-1 is a major determinant of clopidogrel efficacy

(2010) Heleen J Bouman et al.   NATURE MEDICINE

Platelet aggregation pathway

(2010) Katrin Sangkuhl et al.   Pharmacogenetics and Genomics

Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy

(2009) Alan R. Shuldiner   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

(2008) Jessica L. Mega et al.   NEW ENGLAND JOURNAL OF MEDICINE